Exhibit 11.2 INNOVIR LABORATORIES, INC. STATEMENT OF COMPUTATION OF PER SHARE DATA For the nine months ended June 30, --------------------------------------------------------- 1996 1995 --------------------------------------------------------- Fully Fully Primary Diluted Primary Diluted ----------- ----------- ----------- ----------- Net loss ............................................................... ($7,123,896) ($7,123,896) ($3,607,017) ($3,607,017) Reduction of net loss assuming a portion of the proceeds from the exercise of options and warrants was used to repay the Company's term note payable and related accrued interest, and capital lease obligations and to invest in short-term government securities, in accordance with the treasury stock method ............. 1,369,953 ----------- ----------- ----------- ----------- Net loss ............................................................ ($7,123,896) ($7,123,896) ($3,607,017) ($2,237,064) =========== =========== =========== =========== Weighted average number of common shares outstanding ................................................... 4,908,179 4,908,179 3,423,807 3,423,807 Weighted average shares issuable upon conversion of convertible equity securities .......................... 2,101,716 121,187 Shares issuable upon exercise of outstanding options and warrants ..................................... 1,694,019 6,187,023 Shares assumed to be purchased under the treasury stock method ................................................ (1,174,902) (728,205) ----------- ----------- ----------- ----------- Weighted average number of common shares used in computing per share data .............................. 4,908,179 7,529,012 3,423,807 9,003,812 =========== =========== =========== =========== Net loss per share ................................................... ($1.45) ($0.95) ($1.05) ($0.25) =========== =========== =========== ===========